{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:16:45Z","timestamp":1792700205648,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006497","name":"Office of Research and Innovation, Drexel University","doi-asserted-by":"publisher","award":["RP200572"],"award-info":[{"award-number":["RP200572"]}],"id":[{"id":"10.13039\/100006497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["953881"],"award-info":[{"award-number":["953881"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019535","name":"Texas Tech University Health Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019535","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007131","name":"Texas Tech University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001583","name":"Diabetes Action Research and Education Foundation","doi-asserted-by":"publisher","award":["523"],"award-info":[{"award-number":["523"]}],"id":[{"id":"10.13039\/100001583","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.phrs.2025.107900","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:35:23Z","timestamp":1754433323000},"page":"107900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Discovery of pan-EphB tyrosine kinase inhibitor for metabolic syndrome sparing EphB3 signaling in mice"],"prefix":"10.1016","volume":"219","author":[{"given":"Syed","family":"Tareq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba A.","family":"Ewida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaih","family":"Zoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhavalkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanin","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souvik","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Redrovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Nozohouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taysa Berivan","family":"Bassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisson Campos","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi","family":"Frimpong-Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Khodavirdilou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Tareq","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L.","family":"Wilkerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Bickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanth K.","family":"Chelikani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Farag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5600-4698","authenticated-orcid":false,"given":"Mahmoud Salama","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107900_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.biochem.75.103004.142512","article-title":"Obesity-related derangements in metabolic regulation","volume":"75","author":"Muoio","year":"2006","journal-title":"Annu Rev. Biochem"},{"key":"10.1016\/j.phrs.2025.107900_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/ALN.0b013e3181799d45","article-title":"Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms","volume":"109","author":"Martyn","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.phrs.2025.107900_bib3","first-page":"1","article-title":"Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training","author":"Roberts","year":"2013","journal-title":"Compr. Physiol. 3"},{"key":"10.1016\/j.phrs.2025.107900_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4093\/dmj.2020.0250","article-title":"Hyperinsulinemia in obesity, inflammation, and cancer","volume":"45","author":"Zhang","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.phrs.2025.107900_bib5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41591-021-01501-8","article-title":"Obesity and hyperinsulinemia drive adipocytes to activate a cell cycle program and senesce","volume":"27","author":"Li","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2025.107900_bib6","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/js.2019-00065","article-title":"Hyperinsulinemia: an early indicator of metabolic dysfunction","volume":"3","author":"Thomas","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.phrs.2025.107900_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molmet.2015.04.003","article-title":"A major role of insulin in promoting obesity-associated adipose tissue inflammation","volume":"4","author":"Pedersen","year":"2015","journal-title":"Mol. Metab."},{"key":"10.1016\/j.phrs.2025.107900_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/clpt.1994.104","article-title":"Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers","volume":"56","author":"Zhi","year":"1994","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.phrs.2025.107900_bib9","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1001\/jama.293.23.2873","article-title":"Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial","volume":"293","author":"Chanoine","year":"2005","journal-title":"Jama"},{"key":"10.1016\/j.phrs.2025.107900_bib10","article-title":"Unintended consequences of glucagon-like peptide-1 receptor agonists medications in children and adolescents: a call to action","volume":"7","author":"Cooper","year":"2023","journal-title":"J. Clin. Transl. Sci."},{"key":"10.1016\/j.phrs.2025.107900_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3803\/EnM.2019.34.3.247","article-title":"A review of the effects of Glucagon-Like Peptide-1 receptor agonists and Sodium-Glucose cotransporter 2 inhibitors on lean body mass in humans","volume":"34","author":"Sargeant","year":"2019","journal-title":"Endocrinol. Metab. (Seoul. )"},{"key":"10.1016\/j.phrs.2025.107900_bib12","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/jcsm.12434","article-title":"Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy","volume":"10","author":"Hong","year":"2019","journal-title":"J. Cachex.. Sarcopenia Muscle"},{"key":"10.1016\/j.phrs.2025.107900_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00125-019-05065-8","article-title":"Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial","volume":"63","author":"McCrimmon","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2025.107900_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/MPG.0b013e31816232e3","article-title":"Long-term outcome in patients with short bowel syndrome after longitudinal intestinal lengthening and tailoring","volume":"47","author":"Reinshagen","year":"2008","journal-title":"J. Pedia Gastroenterol. Nutr."},{"key":"10.1016\/j.phrs.2025.107900_bib15","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/j.apsb.2023.02.020","article-title":"A potentially serious adverse effect of GLP-1 receptor agonists","volume":"13","author":"Lu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.phrs.2025.107900_bib16","article-title":"Mapping the effectiveness and risks of GLP-1 receptor agonists","author":"Xie","year":"2025","journal-title":"Nat. Med"},{"key":"10.1016\/j.phrs.2025.107900_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053673","article-title":"Involvement of EphB1 receptors signalling in models of inflammatory and neuropathic pain","volume":"8","author":"Cibert-Goton","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2025.107900_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2025.107900_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1744-8069-4-60","article-title":"Targeted mutation of EphB1 receptor prevents development of neuropathic hyperalgesia and physical dependence on morphine in mice","volume":"4","author":"Han","year":"2008","journal-title":"Mol. Pain."},{"key":"10.1016\/j.phrs.2025.107900_bib20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.mehy.2013.02.024","article-title":"Ephrin-Eph signaling as a potential therapeutic target for the treatment of myocardial infarction","volume":"80","author":"O'Neal","year":"2013","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.phrs.2025.107900_bib21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3892\/ol.2022.13436","article-title":"Role of EphB2\/ephrin-B1 signalling in the development and progression of obesity-associated colorectal cancer","volume":"24","author":"Suzuki","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.phrs.2025.107900_bib22","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1172\/JCI85676","article-title":"Disruption of Gpr45 causes reduced hypothalamic POMC expression and obesity","volume":"126","author":"Cui","year":"2016","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.phrs.2025.107900_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002695","article-title":"Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women","volume":"8","author":"Fox","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.phrs.2025.107900_bib24","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1038\/s41598-018-20926-9","article-title":"EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells","volume":"8","author":"Mimche","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2025.107900_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adc9653","article-title":"Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis","volume":"15","author":"Xiao","year":"2023","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.phrs.2025.107900_bib26","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/s42255-022-00634-5","article-title":"Insulin induces insulin receptor degradation in the liver through EphB4","volume":"4","author":"Liu","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.phrs.2025.107900_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/pro.2445","article-title":"Completing the structural family portrait of the human EphB tyrosine kinase domains","volume":"23","author":"Overman","year":"2014","journal-title":"Protein Sci."},{"key":"10.1016\/j.phrs.2025.107900_bib28","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016265118","article-title":"Identification of tetracycline combinations as EphB1 tyrosine kinase inhibitors for treatment of neuropathic pain","volume":"118","author":"Ahmed","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107900_bib29","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20130028","article-title":"Biochemical and biophysical characterization of four EphB kinase domains reveals contrasting thermodynamic, kinetic and inhibition profiles","volume":"33","author":"Overman","year":"2013","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.phrs.2025.107900_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bmcl.2006.09.050","article-title":"Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases","volume":"17","author":"Miyazaki","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2025.107900_bib31","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1016\/j.bmcl.2008.09.087","article-title":"Inhibitors of the tyrosine kinase EphB4. part 2: Structure-based discovery and optimisation of 3,5-bis substituted anilinopyrimidines","volume":"18","author":"Bardelle","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2025.107900_bib32","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1038\/s41467-023-38430-8","article-title":"Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK\/MDM2\/p53 axis","volume":"14","author":"Yan","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107900_bib33","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1158\/1078-0432.CCR-06-2590","article-title":"Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647","volume":"13","author":"Gendreau","year":"2007","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.phrs.2025.107900_bib34","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10456-010-9183-z","article-title":"The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis","volume":"13","author":"Martiny-Baron","year":"2010","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phrs.2025.107900_bib35","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1016\/j.bmcl.2009.05.029","article-title":"Discovery and structural analysis of eph receptor tyrosine kinase inhibitors","volume":"19","author":"Choi","year":"2009","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.phrs.2025.107900_bib36","doi-asserted-by":"crossref","first-page":"6900","DOI":"10.1021\/acs.jcim.3c01064","article-title":"Molecular determinants of EphA2 and EphB2 antagonism enable the design of ligands with improved selectivity","volume":"63","author":"Guidetti","year":"2023","journal-title":"J. Chem. Inf. Model"},{"key":"10.1016\/j.phrs.2025.107900_bib37","doi-asserted-by":"crossref","first-page":"10554","DOI":"10.1021\/jacs.6b05483","article-title":"Development of specific, irreversible inhibitors for a receptor tyrosine kinase EphB3","volume":"138","author":"Kung","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.phrs.2025.107900_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2322934121","article-title":"Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology","volume":"121","author":"Madasu","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.phrs.2025.107900_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/jm0603365","article-title":"Comparison of Shape-Matching and docking as virtual screening tools","volume":"50","author":"Hawkins","year":"2007","journal-title":"J. Med Chem."},{"key":"10.1016\/j.phrs.2025.107900_bib40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: algorithm and validation using high quality structures from the protein databank and cambridge structural database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.phrs.2025.107900_bib41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/ci100436p","article-title":"FRED pose prediction and virtual screening accuracy","volume":"51","author":"McGann","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.phrs.2025.107900_bib42","first-page":"198","article-title":"High-fat diet-induced adipose tissue expansion occurs prior to insulin resistance in C57BL\/6J mice","volume":"6","author":"He","year":"2020","journal-title":"Chronic Dis. Transl. Med"},{"key":"10.1016\/j.phrs.2025.107900_bib43","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/pr100892r","article-title":"Metabolomic analysis of livers and serum from High-Fat diet induced obese mice","volume":"10","author":"Kim","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.phrs.2025.107900_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2021.110270","article-title":"Curcumin alleviates high-fat diet-induced hepatic steatosis and obesity in association with modulation of gut microbiota in mice","volume":"143","author":"Li","year":"2021","journal-title":"Food Res. Int."},{"key":"10.1016\/j.phrs.2025.107900_bib45","article-title":"Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice","volume":"8","author":"Schweiger","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2025.107900_bib46","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1073\/pnas.1802251115","article-title":"Role for fatty acid amide hydrolase (FAAH) in the leptin-mediated effects on feeding and energy balance","volume":"115","author":"Balsevich","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phrs.2025.107900_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.81919","article-title":"A genetic variant of fatty acid amide hydrolase (FAAH) exacerbates hormone-mediated orexigenic feeding in mice","volume":"12","author":"Balsevich","year":"2023","journal-title":"Elife"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825003251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T10:45:14Z","timestamp":1772880314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825003251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":47,"alternative-id":["S1043661825003251"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107900","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of pan-EphB tyrosine kinase inhibitor for metabolic syndrome sparing EphB3 signaling in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107900"}}